Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Recent patents describe novel therapeutic agents for depression, anxiety, etc.

Oct. 25, 2005

Armodafinil improves wakefulness and cognition in patients with sleep disorders

Oct. 25, 2005

FDA clears phase I study of neural stem cells to treat Batten disease

Oct. 25, 2005

CepTor to receive milestone payment for Myodur IND filing

Oct. 25, 2005

NIH grant for Friedreich's ataxia research

Oct. 25, 2005

Quetiapine shows promise in the treatment of bipolar depression

Oct. 25, 2005

Cabergoline reported more effective than L-dopa in idiopathic RLS

Oct. 25, 2005

New data supports the use of pramipexole in restless legs syndrome

Oct. 24, 2005

Therapeutic benefits reported for transdermal lisuride in RLS

Oct. 24, 2005

Approvable letter for Sparlon for ADHD

Oct. 24, 2005

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...